187 related articles for article (PubMed ID: 20100553)
1. Compression behaviour of kappa-carrageenan pellets.
Ghanam D; Hassan I; Kleinebudde P
Int J Pharm; 2010 May; 390(2):117-27. PubMed ID: 20100553
[TBL] [Abstract][Full Text] [Related]
2. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
3. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
4. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
5. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
6. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
Hosseini A; Körber M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
[TBL] [Abstract][Full Text] [Related]
7. Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose.
van Veen B; Bolhuis GK; Wu YS; Zuurman K; Frijlink HW
Eur J Pharm Biopharm; 2005 Jan; 59(1):133-8. PubMed ID: 15567310
[TBL] [Abstract][Full Text] [Related]
8. The degree of compression of spherical granular solids controls the evolution of microstructure and bond probability during compaction.
Nordström J; Persson AS; Lazorova L; Frenning G; Alderborn G
Int J Pharm; 2013 Feb; 442(1-2):3-12. PubMed ID: 22922051
[TBL] [Abstract][Full Text] [Related]
9. Effect of drying on extruded pellets based on kappa-carrageenan.
Thommes M; Blaschek W; Kleinebudde P
Eur J Pharm Sci; 2007 Jun; 31(2):112-8. PubMed ID: 17448646
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of fragmentation during compression of pellets prepared from a 4 to 1 mixture of dicalcium phosphate dihydrate and microcrystalline cellulose.
Nicklasson F; Johansson B; Alderborn G
Eur J Pharm Sci; 1999 Feb; 7(3):221-31. PubMed ID: 9845809
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
[TBL] [Abstract][Full Text] [Related]
12. The effect of shape and porosity on the compression behaviour and tablet forming ability of granular materials formed from microcrystalline cellulose.
Johansson B; Alderborn G
Eur J Pharm Biopharm; 2001 Nov; 52(3):347-57. PubMed ID: 11677077
[TBL] [Abstract][Full Text] [Related]
13. Tabletting behaviour of pellets of a series of porosities--a comparisonbetween pellets of two different compositions.
Nicklasson F; Johansson B; Alderborn G
Eur J Pharm Sci; 1999 Apr; 8(1):11-7. PubMed ID: 10072474
[TBL] [Abstract][Full Text] [Related]
14. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets.
Bashaiwoldu AB; Podczeck F; Newton JM
Eur J Pharm Sci; 2004 Feb; 21(2-3):119-29. PubMed ID: 14757483
[TBL] [Abstract][Full Text] [Related]
15. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
16. Preparation of co-spray dried cushioning agent containing stearic acid for protecting pellet coatings when compressed.
Li X; Xu DS; Li M; Liu L; Heng P
Drug Dev Ind Pharm; 2016; 42(5):788-95. PubMed ID: 26289006
[TBL] [Abstract][Full Text] [Related]
17. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
Krueger C; Thommes M
Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
Balaxi M; Nikolakakis I; Kachrimanis K; Malamataris S
J Pharm Sci; 2009 Feb; 98(2):676-89. PubMed ID: 18548618
[TBL] [Abstract][Full Text] [Related]
19. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
[TBL] [Abstract][Full Text] [Related]
20. Effect of intragranular porosity on compression behaviour of and drug release from reservoir pellets.
Tunón A; Gråsjö J; Alderborn G
Eur J Pharm Sci; 2003 Aug; 19(5):333-44. PubMed ID: 12907284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
